Loading company details...
Beta
Latest Form 4 (Jun 25, 2026): Surendra K. Ajjarapu (Director): In-the-Money Exercise of 100,000 shares, $500.00.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Surendra K. Ajjarapu | In-the-Money Exercise | 100,000 | $500.00 |
| Jun 25, 2026 | Prashant Patel, Chief Executive Officer | In-the-Money Exercise | 100,000 | $500.00 |
| Jun 25, 2026 | Surendra K. Ajjarapu | Grant/Award | 5,000,000 | $1.00M |
| Apr 24, 2026 | Prashant Patel, Chief Executive Officer | Grant/Award | 5,000,000 | $1.00M |
| Jul 8, 2025 | Michael L. Peterson | Grant/Award | 200,000 | $180.0K |
| Mar 25, 2025 | Shafaat Pirani, Chief Clinical Officer | Grant/Award | 35,000 | n/a |
| Mar 25, 2025 | Sajid Syed | Grant/Award | 200,000 | n/a |
| Mar 25, 2025 | Surendra K. Ajjarapu | Grant/Award | 2,882,247 | n/a |
| Mar 25, 2025 | Prashant Patel, Chief Strategy Officer | Grant/Award | 1,882,247 | n/a |
| Mar 25, 2025 | Donald William Anderson | Grant/Award | 200,000 | n/a |